Anti-PD 1 Brain Collaboration + Radiotherapy Extension: The ABC-X Study

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2006415

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The purpose of this research study is to determine whether administering radiotherapy to melanoma brain tumours, in combination with 2 drugs called nivolumab and ipilimumab(also known as Immunotherapy), will be more effective than treating brain tumours with immunotherapy. Patients in this trial will be randomly assigned to 1 of 2 treatment groups. Group 1 will receive radiotherapy to their melanoma brain lesion(s), combined with immunotherapy. Group 2 will receive immunotherapy treatment alone.

Funded Activity Details

Start Date: 01-01-2021

End Date: End date not available

Funding Scheme: Clinical Trials and Cohort Studies Grants

Funding Amount: $1,010,141.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

brain lesion | cancer immunotherapy | cohort study | radiotherapy

Related Links